Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Proliferating Brenner tumor

S H Chang, J M Roberts, H D Homesley

    Obstetrics and Gynecology
    |April 1, 1977
    PubMed
    Summary
    This summary is machine-generated.

    Proliferating Brenner tumor is a rare ovarian neoplasm. This case highlights its benign nature, with no reported recurrences in any patients, emphasizing its favorable prognosis.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Feasibility of laparoscopic management of presumed stage I endometrial carcinoma and assessment of accuracy of myoinvasion estimates by frozen section: a gynecologic oncology group study.

    International journal of gynecological cancer : official journal of the International Gynecological Cancer Society·2004
    Same author

    A dose-escalating study of weekly bolus topotecan in previously treated ovarian cancer patients.

    Gynecologic oncology·2001
    Same author

    Tamoxifen in the treatment of advanced or recurrent endometrial carcinoma: a Gynecologic Oncology Group study.

    Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2001
    Same author

    Oral medroxyprogesterone acetate in the treatment of advanced or recurrent endometrial carcinoma: a dose-response study by the Gynecologic Oncology Group.

    Journal of clinical oncology : official journal of the American Society of Clinical Oncology·1999
    Same author

    A new pathway for mitogen-dependent cdk2 regulation uncovered in p27(Kip1)-deficient cells.

    Current biology : CB·1999
    Same author

    Modulation of apoptosis by the cyclin-dependent kinase inhibitor p27(Kip1).

    The Journal of clinical investigation·1999
    Same journal

    The Political Determinants of Obstetric Prescribing.

    Obstetrics and gynecology·2026
    Same journal

    Glucagon-Like Peptide-1 Receptor Agonists and Risk of Adverse Maternal Pregnancy Outcomes: A Systematic Review and Meta-analysis.

    Obstetrics and gynecology·2026
    Same journal

    Milestones in Motion: Vaginal Birth After Cesarean.

    Obstetrics and gynecology·2026
    Same journal

    Ebola Virus in Pregnancy.

    Obstetrics and gynecology·2026
    Same journal

    A Quality-Improvement Study Evaluating Three Postpartum Prophylactic Oxytocin Rates and Blood Loss After Vaginal Birth.

    Obstetrics and gynecology·2026
    Same journal

    The Effects of Climate Change on Obstetric and Gynecologic Health.

    Obstetrics and gynecology·2026
    See all related articles

    Area of Science:

    • Gynecologic pathology
    • Ovarian neoplasms
    • Oncology

    Background:

    • Proliferating Brenner tumor (PBT) is an uncommon variant of Brenner tumor.
    • Fewer than 20 cases have been documented in medical literature.
    • Understanding PBT's clinicopathologic features is crucial for accurate diagnosis and management.

    Observation:

    • This report details a specific case of proliferating Brenner tumor.
    • Emphasis is placed on the detailed pathological and histological examination.
    • The presented case contributes to the limited existing data on PBT.

    Findings:

    • Proliferating Brenner tumors are histologically characterized by specific cellular and stromal features.
    • The current case aligns with the established pathological criteria for PBT.

    Related Experiment Videos

  • Crucially, no evidence of recurrence was observed in this patient.

    • Implications:

    • The findings support the classification of proliferating Brenner tumor as a benign entity.
    • This suggests a favorable clinical outcome for patients diagnosed with PBT.
    • Further research into PBT can refine diagnostic criteria and treatment strategies.